KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nov (NOV) Gains from Sales and Divestitures (2016 - 2025)

Nov's Gains from Sales and Divestitures history spans 16 years, with the latest figure at $2.9 million for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures fell 5.56% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $2.9 million, down 5.56%, while the annual FY2025 figure was $2.9 million, 5.56% down from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $2.9 million at Nov, down from $3.1 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $3.1 million in Q4 2024 and bottomed at $2.7 million in Q4 2021.
  • The 5-year median for Gains from Sales and Divestitures is $2.9 million (2025), against an average of $2.9 million.
  • The largest annual shift saw Gains from Sales and Divestitures dropped 17.25% in 2021 before it grew 7.14% in 2022.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $2.7 million in 2021, then increased by 7.14% to $2.9 million in 2022, then rose by 6.35% to $3.0 million in 2023, then grew by 0.78% to $3.1 million in 2024, then decreased by 5.56% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for NOV's Gains from Sales and Divestitures are $2.9 million (Q4 2025), $3.1 million (Q4 2024), and $3.0 million (Q4 2023).